Interactions Between Thiopurine Metabolites and Adalimumab and Anti-adalimumab Antibodies in Inflammatory Bowel Disease

被引：0
|
作者：
Holmstrom, Rikke [1 ]
Mogensen, Ditte [1 ]
Brynskov, Jorn [1 ]
Ainsworth, Mark [1 ]
Nersting, Jacob [2 ]
Schmiegelow, Kjeld [2 ]
Steenholdt, Casper [1 ]
机构：
[1] Univ Copenhagen, Herlev Hosp, Dept Gastroenterol, Herlev, Denmark
[2] Univ Copenhagen Hosp, Rigshosp, Pediat Oncol Res Lab, Copenhagen, Denmark
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-120
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease
    Holmstrom, Rikke B.
    Mogensen, Ditte V.
    Brynskov, Jorn
    Ainsworth, Mark A.
    Nersting, Jacob
    Schmiegelow, Kjeld
    Steenholdt, Casper
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (06) : 1583 - 1591
  • [2] Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease
    Rikke B. Holmstrøm
    Ditte V. Mogensen
    Jørn Brynskov
    Mark A. Ainsworth
    Jacob Nersting
    Kjeld Schmiegelow
    Casper Steenholdt
    [J]. Digestive Diseases and Sciences, 2018, 63 : 1583 - 1591
  • [3] Adalimumab/naproxenLack of efficacy and anti-adalimumab antibodies: case report
    [J]. Reactions Weekly, 2021, 1866 (1) : 17 - 17
  • [4] Antibodies Against Infliximab Are Associated With Increased Risk of Anti-Adalimumab Antibody Development in Patients With Inflammatory Bowel Disease
    Frederiksen, Madeline T.
    Ainsworth, Mark A.
    Brynskov, Jorn
    Thomsen, Ole
    Bendtzen, Klaus
    Steenholdt, Casper
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S238 - S238
  • [5] Antibodies against infliximab are associated with increased risk of anti-adalimumab antibody development in patients with inflammatory bowel disease
    Frederiksen, M. T.
    Ainsworth, M. A.
    Brynskov, J.
    Thomsen, O. O.
    Bendtzen, K.
    Steenholdt, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S300 - S300
  • [6] Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis
    van Kuijk, A. W. R.
    de Groot, M.
    Stapel, S. O.
    Dijkmans, B. A. C.
    Wolbink, G. J.
    Tak, P. P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) : 624 - U187
  • [7] Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
    Bartelds, Geertje M.
    Wijbrandts, Carla A.
    Nurmohamed, Michael T.
    Stapel, Steven
    Lems, Willem F.
    Aarden, Lucien
    Dijkmans, Ben A. C.
    Tak, Paul Peter
    Wolbink, Gerrit Jan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) : 921 - 926
  • [8] AdalimumabDevelopment of anti-adalimumab antibodies: case report
    [J]. Reactions Weekly, 2018, 1732 (1) : 22 - 22
  • [9] Thromboembolic Events Are Not Associated with Anti-Adalimumab Antibodies
    Burmester, Gerd
    Gabay, Cem
    Arikan, Dilek
    Cardoso, Anabela
    Kalabic, Jasmina
    Pfeifer, Nathan
    Varothai, Nupun A.
    Florentinus, Stefan
    Smolen, Josef S.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] Anti-adalimumab Antibodies in Patients with Non-infectious Ocular Inflammatory Disease: A Case Series
    McKay, K. Matthew
    Apostolopoulos, Nicholas
    Chou, Brian
    Leveque, Thellea K.
    Van Gelder, Russell N.
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (7-8) : 1721 - 1725
12345